Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
2.185
+0.025 (1.16%)
Nov 21, 2024, 10:42 AM EST - Market open
Akoya Biosciences Market Cap
Akoya Biosciences has a market cap or net worth of $108.30 million as of November 21, 2024. Its market cap has decreased by -41.61% in one year.
Market Cap
108.30M
Enterprise Value
152.68M
1-Year Change
-41.61%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since the IPO on April 16, 2021, Akoya Biosciences's market cap has decreased from $713.79M to $108.30M, a decrease of -84.83%. That is a compound annual growth rate of -40.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 107.06M | -55.30% |
| Dec 29, 2023 | 239.49M | -34.07% |
| Dec 30, 2022 | 363.24M | -36.24% |
| Dec 31, 2021 | 569.65M | -20.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 115.16M |
| TELA Bio | 114.23M |
| Cabaletta Bio | 110.46M |
| Journey Medical | 108.40M |
| Century Therapeutics | 107.14M |
| Cidara Therapeutics | 106.55M |
| MultiPlan | 104.30M |
| Quipt Home Medical | 103.69M |